Dr Reddy’s launches Cinacalcet Tablets in US
They are available in 30 mg, 60 mg, and 90 mg tablets in a bottle count size of 30
Dr Reddy’s Laboratories announced the launch of Cinacalcet Tablets, a therapeutic equivalent generic version of Sensipar (cinacalcet) Tablets, approved by the US Food and Drug Administration (USFDA).
Dr Reddy’s Cinacalcet Tablets are available in 30 mg, 60 mg, and 90 mg tablets in a bottle count size of 30.
Cinacalcet tablet is a positive modulator of the calcium-sensing receptor indicated for:
- Secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. They are not indicated for use in patients with CKD who are not on dialysis
- Hypercalcemia in adult patients with parathyroid carcinoma (PC)
- Severe hypercalcemia in adult patients with primary HPT who are unable to undergo parathyroidectomy
The Sensipar brand and generic market had US sales of approximately $312 million MAT for the most recent twelve months ending in July 2020 according to IQVIA Health*.